Zeit | Aktuelle Nachrichten | Rating | Leser | ||
---|---|---|---|---|---|
Mi | CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza ; Development in Collaboration with GSK | 625 | Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza (H5N1) virus, considered to be potential future pandemic threatStudy will... ► Artikel lesen | ||
Mi | Alta Global Group: Alta Academy Teams Up with UFC legend Daniel Cormier to Elevate Wrestling Training Worldwide | 305 | SYDNEY, AUSTRALIA / ACCESSWIRE / April 24, 2024 / Alta Global Group (NYSE American:MMA) ("Alta" or the "Company"), a leading name in martial arts and combat sports training, announced its latest collaboration... ► Artikel lesen | ||
Mi | Coppernico Metals Inc.: Coppernico Receives Final Permits to Drill its Sombrero Copper-Gold Project in Southern Peru | 253 | VANCOUVER, BC / ACCESSWIRE / April 24, 2024 / Coppernico Metals Inc. ("Coppernico" or the "Company") is pleased to announce that its Peruvian subsidiary Sombrero Minerales S.A.C. has now received all... ► Artikel lesen | ||
Mi | Senzime publishes annual and sustainability report for 2023 | 97 | UPPSALA, SE / ACCESSWIRE / April 24, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ) announces today that the company's annual and sustainability report for 2023 is published and available... ► Artikel lesen | ||
Mi | Xcyte Digital Corp. to Present at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 2024 | 93 | POMPANO BEACH, FL / ACCESSWIRE / April 24, 2024 / Xcyte Digital Corp. (TSXV:XCYT) ("Xcyte" or the "Company"), a spatial computing event technology aggregator and developer providing a high value, cost-effective... ► Artikel lesen | ||
Mi | Theralase Technologies Inc.: Theralase Closes $CAN 750,000 Non-Brokered Private Placement | 165 | TORONTO, ON / ACCESSWIRE / April 24, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF)(FRA:TTX), a clinical stage pharmaceutical company dedicated to the research... ► Artikel lesen | ||
Mi | Nutriband Inc.: Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa Fentanyl Transdermal Patch Through FDA Submission | 227 | Private Placement of $8.4 million has closed and will fund the commercial development of lead product AVERSA Fentanyl to NDA filingNutriband working to complete the commercial scale-up prior to performing... ► Artikel lesen | ||
Mi | Ecora Resources PLC Announces Transaction in Own Shares | 112 | Transaction in Own Shares LONDON, UK / ACCESSWIRE / April 24, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) announces that on 23 April 2024, it purchased 250,000 ordinary shares of 2p each in the... ► Artikel lesen | ||
Mi | Aston Bay Holdings Ltd: Aston Bay Signs Definitive Agreement to Option the Epworth Sediment Hosted Copper-Silver-Zinc-Cobalt Project, Nunavut, Canada; Dr. Elizabeth Turner Joins Advisory Board | 317 | Expanding Aston Bay's large-scale high-grade copper portfolio TORONTO, ON / ACCESSWIRE / April 24, 2024 / Aston Bay Holdings Ltd. (TSX-V:BAY)(OTCQB:ATBHF) (the "Company" or "Aston Bay") is pleased to... ► Artikel lesen | ||
Mi | enVVeno Medical Corporation: Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium | 148 | Overall 8.46 Average Revised Venous Clinical Severity Score (rVCSS) Improvement Per Patient for Patients Showing Clinical Meaningful Benefit (rVCSS Improvement = 3 Points) including:9.29 Points for... ► Artikel lesen | ||
Mi | Tryp Therapeutics Provides Update on Plan of Arrangement With Exopharm Limited and Announces Voluntary Trading Halt | 163 | KELOWNA, BC / ACCESSWIRE / April 24, 2024 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP)(OTCQB:TRYPF) is pleased to announce that the shareholders of Exopharm Limited ACN 163 765 991... ► Artikel lesen | ||
Mi | Epique Realty Empowers Agents at PowerCON 2024 with More Free Benefits: Realty.com | 124 | Epique Realty sparks excitement once again by unveiling a unique and marvelous benefit for its agents with Realty.com HOUSTON, TX / ACCESSWIRE / April 24, 2024 / On the exhilarating second day of PowerCON... ► Artikel lesen | ||
Mi | Benefits for Agents Keep on Coming at PowerCON as Epique Realty Introduces CliqueOffers | 123 | The momentum of excitement continues at PowerCON as Epique Realty unveils yet another valuable free benefit for agents: CliqueOffers HOUSTON, TX / ACCESSWIRE / April 24, 2024 / The momentum of excitement... ► Artikel lesen | ||
Mi | Bioz, Inc.: NeuroNexus is Leveraging Bioz's AI-Powered Citation Tools to Drive Increased Sales Conversion | 97 | PALO ALTO, CA / ACCESSWIRE / April 24, 2024 / Bioz, Inc., a Silicon Valley AI company, has partnered with NeuroNexus to provide a suite of digital citation widgets that display NeuroNexus' peer-reviewed... ► Artikel lesen | ||
Mi | Senzime Wins Another Major US Veterans Affairs Contract; Expands Reach of TetraGraph System | 141 | UPPSALA, SE / ACCESSWIRE / April 24, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in perioperative precision-based patient monitoring solutions, announced today that it has been... ► Artikel lesen | ||
Mi | CESI Spa: CESI Solar Cells Fuels the Satellites of the Global Internet | 177 | MILAN, ITALY / ACCESSWIRE / April 24, 2024 / The Italian group CESI has secured a contract, with options valued at over one hundred million euros over five years, with one of the world's leading companies... ► Artikel lesen | ||
Mi | BioInvent International AB: Interim Report January-March 2024 | 108 | LUND, SWEDEN / ACCESSWIRE / April 24, 2024 / BioInvent International (STO:BINV)"During the first quarter of the year, we continued making excellent progress with our clinical pipeline targeting TNFR2... ► Artikel lesen | ||
Mi | Spago Nanomedical Reports Favorable Data in Breast Cancer Model with Tumorad | 119 | LUND, SWEDEN / ACCESSWIRE / April 24, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today data from a non-clinical study exploring 177Lu-SN201 in a model for... ► Artikel lesen | ||
Mi | Ecora Resources PLC Announces Q1 2024 Trading Update | 260 | LONDON, UK / ACCESSWIRE / April 24, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) issues the following trading update for the period 1 January to 31 March 2024.Ecora is the leading royalty company... ► Artikel lesen | ||
Mi | Angle PLC Announces New Commercial Agreement with AstraZeneca | 120 | ANGLE signs agreement to tailor existing Parsortix-based DNA damage response assay for use in pharmaceutical R&D GUILDFORD, SURREY / ACCESSWIRE / April 24, 2024 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a... ► Artikel lesen | ||
Mi | InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 24 | 78 | LONDON, UK / ACCESSWIRE / April 24, 2024 / The Company announces that on 23 April 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International... ► Artikel lesen | ||
Mi | XVIVO Perfusion AB: Interim Report January-March 2024 | 159 | GOTHENBURG, SWEDEN / ACCESSWIRE / April 24, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)First quarter 2024 (Jan 1 - Mar 31)• Net sales amounted to SEK 186.0 million (140.6), corresponding... ► Artikel lesen | ||
Mi | Epique Realty Amazes Agents at PowerCON 2024 with Another Free Benefit: REDO by BASE | 136 | Epique unveils REDO by BASE, which is a progressive remodeling software service that empowers buyers to visualize their dream homes with incomparable precision. HOUSTON, TX / ACCESSWIRE / April 24,... ► Artikel lesen | ||
Mi | Kuros Biosciences AG: Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales | 297 | Financial HighlightsDirect MagnetOs sales rose by 155% to CHF 13.9 million in Q1 2024 from CHF 5.4 million in Q1 2023; this corresponds to a sequential increase of 21.9% or CHF 2.5 million over Q4 2023Total... ► Artikel lesen | ||
Mi | Evotec SE: Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth | 319 | FINANCIAL RESULTS FOR 2023 FULLY MET UPDATED GUIDANCEPRIORITY RESET TO PROFITABLE GROWTH: SIZE & FOOTPRINT ADJUSTMENTS TO DRIVE EXPECTED ANNUALISED EBITDA IMPROVEMENT GREATER THAN € 40 MEVOTEC'S REPORTING... ► Artikel lesen |